NIH-funded research R01 grant

Psilocybin-assisted therapy for distress in advanced cancer

Official title: Psilocybin Therapy for Advanced Cancer-related Psychiatric Distress

Funded at New York University School of Medicine · NIH-11348885 · Data updated 2026-11-12

This grant tests whether psilocybin-assisted therapy can reduce anxiety, depression, and existential distress in people with advanced cancer.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionNew York University School of Medicine
NIH-funded
Lab location1 site (New York, United States)
Project startJuly 4, 2022
Project endJune 30, 2027
Funding year2026
Award (this year)$668,332
NIH project number5R01CA268521-05
Project IDNIH-11348885 on NIH RePORTER

Who could benefit from this research

Could help

Adults with advanced or terminal cancer experiencing clinically significant anxiety, depression, or existential distress.

Less likely to help

Patients without distress or those unable to participate in psilocybin-assisted therapy may not benefit.

What this research studies

If you have advanced cancer and feel anxious, depressed, or lacking meaning, this research explores psilocybin-assisted therapy as a potential treatment option. The study builds on earlier, smaller trials that suggested the approach can be safe and may improve mood, meaning, and quality of life. Participants would receive structured psychotherapy alongside controlled psilocybin sessions and follow-up assessments to understand how it affects well-being over time. The goal is to find a treatment that eases suffering and supports hopeful engagement with care.

Why it matters

Potential benefit: If successful, patients could experience reduced distress and improved quality of life during a challenging period of illness.

How similar studies have gone: Earlier small studies have shown safety and potential benefits in similar settings, but larger trials are needed.

Where this research is happening

  • New York University School of Medicine
    New York, United States
    Active

Researchers

  • Principal investigator: Ross, Stephen — New York University School of Medicine
  • Study coordinator: Ross, Stephen

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.